Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03318
Species: Homo sapiens
Position : chr11:2219531-2239062
Year: 2017
Title: Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.
Genome Build: hg19
Enhancer Type: Super-enhancer
Condition: Disease
Disease Name: Lung Cancer
PMID:  27869826
Tissue: lung
Tissue Ontology ID: UBERON:0002048
Cell Source: HCC-15
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay; TF-binding/chromatin assay; Chromatin interaction assay; Disease-associated enhancer analysis
High Throughput Method: ChIP-seq; 4C-seq
Low Throughput Method: Luciferase reporter assay; Reporter assay; ChIP-qPCR/ChIP
About Target Gene
Target gene : IGF2
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 8 found
Enhancer ID Position Tissue Cell Disease
E_03293 chr11:2218986-2222624 colon malignant cell colorectal cancer
E_01649 chr11:2223156-2236495 colon malignant cell colorectal adenocarcinoma
E_03294 chr11:2227598-2233058 colon malignant cell colorectal cancer
E_01618 chr11:2233643-2234213 colon epithelial cell colorectal adenocarcinoma
E_01645 chr11:2233643-2234213 colon malignant cell colorectal adenocarcinoma
E_01646 chr11:2233643-2234213 colon malignant cell colorectal adenocarcinoma
E_03295 chr11:2234046-2237062 colon malignant cell colorectal cancer
E_03296 chr11:2236031-2239626 colon malignant cell colorectal cancer
Expression of Target Genes for the Enhancer